Adirondack Funds’s Pfizer PFE Stock Holding History

Adirondack Funds’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$327K	Buy	+10,988	New	+$352K	0.13%	94

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Adirondack Funds's PFE Position: Q3 2015 in Review

Adirondack Funds opened a new position in Pfizer (PFE) in Q3 2015: 10,988 shares worth $327K. The stake represents 0.13% of the portfolio and ranks #94 among its holdings.

1,880 funds tracked by Wall St. Rank hold PFE as of Q3 2015.

Adirondack Funds held 10,988 shares of Pfizer worth $327K as of Q3 2015.
Pfizer was a new Adirondack Funds position in Q3 2015.
Pfizer made up 0.13% of Adirondack Funds's portfolio in Q3 2015, its #94 holding.
1,880 funds tracked by Wall St. Rank held Pfizer as of Q3 2015.

Based on Adirondack Funds's 13F filing for Q3 2015, filed 10 Nov 2015.